CN Stock MarketDetailed Quotes
000597 Northeast Pharmaceutical Group
- 5.10
- -0.17-3.23%
Noon Break Jan 10 11:30 CST
7.29BMarket Cap20.99P/E (TTM)
5.36High5.09Low281.65KlotVolume5.23Open5.27Pre Close145.44MTurnover2.01%Turnover Ratio20.32P/E (Static)1.43BShares6.6952wk High1.41P/B7.15BFloat Cap3.6752wk Low5.80Limit Up1.40BShs Float12.84Historical High4.74Limit Down5.12%Amplitude0.69Historical Low0.10Dividend TTM5.16Avg Price153.46KlotAsk1.96%Div YieldTTM100Lot Size127.69KlotBid
Northeast Pharmaceutical Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -4.22%6.13B | -7.50%4.17B | -17.58%1.94B | -6.42%8.24B | -2.52%6.4B | 1.95%4.51B | 0.02%2.35B | 8.15%8.81B | 7.60%6.57B | 10.23%4.42B |
| Operating revenue | -4.22%6.13B | -7.50%4.17B | -17.58%1.94B | -6.42%8.24B | -2.52%6.4B | 1.95%4.51B | 0.02%2.35B | 8.15%8.81B | 7.60%6.57B | 10.23%4.42B |
| Other operating revenue | ---- | -43.47%16.59M | ---- | -34.58%58.56M | ---- | 7.31%29.36M | ---- | -9.32%89.5M | ---- | -33.83%27.36M |
| Total operating cost | -4.02%5.78B | -8.67%3.88B | -18.64%1.82B | -9.14%7.66B | -3.92%6.03B | 0.95%4.25B | -0.78%2.24B | 5.83%8.44B | 4.09%6.27B | 7.69%4.21B |
| Operating cost | 6.16%4.02B | 4.69%2.69B | -9.10%1.2B | -9.06%4.89B | -6.16%3.78B | -5.23%2.57B | -8.33%1.32B | 9.10%5.38B | 8.49%4.03B | 12.68%2.71B |
| Operating tax surcharges | -13.62%53.45M | -17.44%35.59M | -19.35%17.67M | -1.66%81.75M | 0.64%61.88M | 4.34%43.1M | 6.72%21.91M | -0.88%83.13M | -5.84%61.49M | -1.86%41.31M |
| Operating expense | -29.25%1.05B | -34.77%723.18M | -33.89%386.75M | -11.76%1.81B | -0.72%1.48B | 12.38%1.11B | 9.82%585.04M | 1.72%2.05B | -0.10%1.49B | -0.42%986.54M |
| Administration expense | -12.54%619.71M | -24.86%422.33M | -33.67%204.15M | 7.92%815.55M | 11.19%708.52M | 28.90%562.04M | 32.06%307.76M | 1.75%755.71M | 1.13%637.2M | 11.22%436.03M |
| Financial expense | 87.54%-6.24M | 55.98%-25.48M | 46.68%-5.84M | -478.84%-29.97M | -774.81%-50.08M | -1,152.19%-57.9M | -263.89%-10.95M | -93.13%7.91M | -106.54%-5.72M | -108.03%-4.62M |
| -Interest expense (Financial expense) | -6.47%53.03M | -10.79%35.97M | -8.57%17.9M | -15.98%77.39M | -16.81%56.7M | -8.77%40.32M | -12.66%19.57M | -23.34%92.11M | -23.75%68.15M | -27.59%44.2M |
| -Interest Income (Financial expense) | 18.04%-101.23M | 23.53%-77.18M | 32.17%-25.69M | -65.18%-155.08M | -82.97%-123.52M | -130.11%-100.93M | -91.35%-37.87M | -67.88%-93.88M | -142.07%-67.51M | -125.08%-43.86M |
| Research and development | 26.41%53.42M | 44.02%35.98M | 34.34%17.04M | -39.50%97.04M | -25.31%42.26M | -36.95%24.98M | -40.05%12.68M | 92.18%160.39M | 66.37%56.58M | 87.90%39.63M |
| Credit Impairment Loss | -156.48%-1.67M | -413.52%-2.98M | 138.62%257.5K | 132.47%6.79M | 137.78%2.96M | 109.95%952.08K | 83.26%-666.68K | -31.24%-20.9M | -453.54%-7.84M | -440.53%-9.57M |
| Asset Impairment Loss | 41.13%-81.63M | 47.46%-66.27M | -11.76%-37.67M | -30.54%-193.49M | -27.15%-138.66M | -57.42%-126.12M | -22.91%-33.7M | -55.39%-148.23M | -142.15%-109.06M | -108.92%-80.11M |
| Other net revenue | 78.38%-13.99M | 88.28%-7.56M | 68.83%-3.51M | -124.99%-80.67M | 8.14%-64.72M | -0.41%-64.47M | 26.56%-11.26M | 2,437.36%322.84M | -4,935.75%-70.46M | -500.50%-64.21M |
| Invest income | -58.48%3.44M | -61.52%2.93M | --2.27M | --8.61M | --8.29M | --7.62M | ---- | ---- | --0 | ---- |
| Asset deal income | -96.15%6.65K | -96.17%6.65K | -90.86%6.65K | -99.96%172.21K | 500.58%172.91K | 328.89%173.92K | 79.48%72.78K | 12,641.67%419.3M | -101.96%-43.16K | 1,263.60%40.55K |
| Other revenue | 5.35%65.86M | 11.08%58.75M | 37.26%31.62M | 33.84%97.26M | 34.49%62.51M | 107.98%52.9M | 43.71%23.04M | 9.40%72.67M | 18.51%46.48M | 2.38%25.43M |
| Operating profit | 7.21%336.36M | 46.05%278.3M | 10.06%117.67M | -28.45%498.23M | 37.80%313.74M | 31.77%190.56M | 26.22%106.92M | 271.69%696.36M | 188.73%227.67M | 63.51%144.61M |
| Add:Non operating Income | 5.72%15.95M | -52.26%3.83M | -68.65%2.36M | -4.71%28.99M | -25.24%15.09M | -50.02%8.02M | 260.63%7.54M | 344.36%30.43M | 436.46%20.18M | 551.38%16.04M |
| Less:Non operating expense | -87.00%3.27M | -25.54%3.37M | 6,746.51%3.6M | -80.61%39.05M | -35.90%25.18M | 376.06%4.53M | -93.75%52.53K | 171.96%201.34M | 44.57%39.28M | -90.81%950.9K |
| Total profit | 14.95%349.04M | 43.66%278.76M | 1.78%116.43M | -7.09%488.17M | 45.59%303.64M | 21.51%194.05M | 33.09%114.4M | 337.27%525.44M | 276.18%208.57M | 98.24%159.7M |
| Less:Income tax cost | 86.47%128.98M | 127.28%111.86M | 37.75%56.65M | -33.33%112.19M | -3.85%69.17M | 20.38%49.22M | 207.79%41.13M | 580.72%168.28M | 170.76%71.94M | 131.72%40.88M |
| Net profit | -6.15%220.05M | 15.24%166.89M | -18.41%59.78M | 5.27%375.98M | 71.62%234.47M | 21.90%144.83M | 0.94%73.27M | 274.22%357.16M | 373.20%136.63M | 88.85%118.81M |
| Net profit from continuing operation | -6.15%220.05M | 15.24%166.89M | -18.41%59.78M | 5.27%375.98M | 71.62%234.47M | 21.90%144.83M | 0.94%73.27M | 274.22%357.16M | 373.20%136.63M | 88.85%118.81M |
| Less:Minority Profit | -17.74%12.09M | 1.43%10.09M | -33.40%2.15M | 153.76%17.52M | 73.10%14.69M | 59.80%9.94M | -24.36%3.22M | 292.55%6.9M | 151.46%8.49M | 146.05%6.22M |
| Net profit of parent company owners | -5.37%207.97M | 16.25%156.81M | -17.72%57.63M | 2.34%358.46M | 71.52%219.78M | 19.80%134.89M | 2.51%70.05M | 253.69%350.25M | 402.55%128.14M | 86.46%112.59M |
| Earning per share | ||||||||||
| Basic earning per share | -5.03%0.1455 | 17.02%0.11 | -18.37%0.04 | 0.00%0.25 | 63.15%0.1532 | 12.57%0.094 | -3.92%0.049 | 257.14%0.25 | 396.83%0.0939 | 85.56%0.0835 |
| Diluted earning per share | -5.03%0.1455 | 17.02%0.11 | -18.37%0.04 | 0.00%0.25 | 63.15%0.1532 | 12.57%0.094 | -3.92%0.049 | 257.14%0.25 | 396.83%0.0939 | 85.56%0.0835 |
| Other composite income | -131.84%-451.41K | -85.24%238.72K | 135.84%66.13K | -69.04%921.94K | -63.85%1.42M | -11.33%1.62M | -42.26%-184.5K | 619.62%2.98M | 3,657.81%3.92M | 971.61%1.82M |
| Other composite income of parent company owners | -131.98%-453.41K | -85.18%239.91K | 134.51%66.47K | -69.13%919.41K | -63.98%1.42M | -11.62%1.62M | -46.92%-192.64K | 619.62%2.98M | 3,636.47%3.94M | 968.07%1.83M |
| Other composite income of minority owners | 2,675.74%1.99K | 8.59%-1.19K | -104.23%-344.1 | --2.53K | 99.44%-77.36 | 82.84%-1.3K | 470.47%8.14K | ---- | -1,403.55%-13.73K | -539.81%-7.6K |
| Total composite income | -6.90%219.6M | 14.13%167.13M | -18.12%59.85M | 4.66%376.9M | 67.83%235.89M | 21.39%146.45M | 0.86%73.09M | 279.62%360.13M | 388.65%140.55M | 92.39%120.64M |
| Total composite income of parent company owners | -6.19%207.52M | 15.05%157.05M | -17.40%57.7M | 1.74%359.38M | 67.48%221.2M | 19.30%136.5M | 2.43%69.86M | 258.78%353.23M | 420.26%132.07M | 90.16%114.42M |
| Total composite income of minority owners | -17.72%12.09M | 1.43%10.08M | -33.58%2.15M | 153.80%17.52M | 73.38%14.69M | 59.97%9.94M | -24.19%3.23M | 292.55%6.9M | 150.98%8.47M | 145.59%6.21M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
